http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Ji Yon Agnes Jang,Nozomu Yanaihara,Eric Pujade-Lauraine,Yoshiki Mikami,Katsutoshi Oda,Michael Bookman,Jonathan Ledermann,Muneaki Shimada,Takako Kiyokawa,김병기,Noriomi Matsumura,Tsunehisa Kaku,Takafumi K 대한부인종양학회 2017 Journal of Gynecologic Oncology Vol.28 No.4
There has been significant progress in the understanding of the pathology and molecular biologyof rare ovarian cancers, which has helped both diagnosis and treatment. This paper provides anupdate on recent advances in the knowledge and treatment of rare ovarian cancers and identifiesgaps that need to be addressed by further clinical research. The topics covered include: low-gradeserous, mucinous, and clear cell carcinomas of the ovary. Given the molecular heterogeneity andthe histopathological rarity of these ovarian cancers, the importance of designing adequatelypowered trials or finding statistically innovative ways to approach the treatment of these raretumors has been emphasized. This paper is based on the Rare Ovarian Tumors Conferencefor Young Investigators which was presented in Tokyo 2015 prior to the 5th Ovarian CancerConsensus Conference of the Gynecologic Cancer InterGroup (GCIG).